RFK re­moves all ACIP mem­bers, names new ones; Na­tion­al Re­silience to close six sites; Deals and fi­nanc­ing re­cap of ...

Yesterday
Weekly

For­mer CEO Anne Wo­j­ci­c­ki wins bid for 23andMe

Yesterday
Deals
Health Tech

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

Yesterday
Pharma
FDA+

FDA's on­col­o­gy ad­comm to re­view GSK's Blenrep re­launch plans

Yesterday
Pharma
FDA+

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

Yesterday
People
FDA+

With HIV pre­ven­tion un­der at­tack, how might Gilead’s new PrEP in­jec­tion fare?

2 days ago
Pharma
In Focus

Rein Ther­a­peu­tics study on clin­i­cal hold; Beam up­dates sick­le cell ther­a­py da­ta

2 days ago
News Briefing

Bris­tol My­ers gets a key strate­gist with 'Team Shib­s'; Idor­sia to change CEOs af­ter it 'hit a re­set but­ton'

2 days ago
Peer Review

As­traZeneca inks AI drug R&D deal with Chi­nese phar­ma for $110M up­front 

2 days ago
R&D
China

Mod­er­na wins ex­pand­ed la­bel for RSV shot, al­low­ing use in at-risk, younger adults

2 days ago
Pharma
FDA+

Min­neso­ta gener­ic drug pric­ing law is like­ly un­con­sti­tu­tion­al, ap­peals court rules

2 days ago
Pharma
Law

No­vo Nordisk plans Phase 3 tri­als of oral, in­jectable amy­cretin for ear­ly 2026

2 days ago
R&D
Pharma

Kennedy's vac­cine doubts hinge on 'in­ert' place­bos, but ex­perts say he mis­un­der­stands the sci­ence

2 days ago
Pharma
FDA+

Cure­Vac CEO on BioN­Tech deal: Come to­geth­er 'rather than fight­ing each oth­er in court'

2 days ago
Deals

An­oth­er care nav­i­ga­tion deal

2 days ago
Health Tech

In sur­prise, FDA ap­proves Uro­Gen's chemo-turned-gel drug af­ter neg­a­tive ad­comm vote

2 days ago
Pharma
FDA+

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

2 days ago
R&D
Pharma

In­smed aims to raise $750M in one of the largest stock of­fer­ings this year

2 days ago
Financing
R&D

Ku­ra, Ky­owa say Phase 1 up­date sup­ports menin in­hibitor com­bos 

2 days ago
R&D

ADC Ther­a­peu­tics re­veals lay­offs, $100M PIPE; Third Har­mon­ic seeks buy­er for as­set

3 days ago
News Briefing

Capri­cor gets Form 483 from FDA; WuXi Bi­o­log­ic­s' new Chi­na fac­to­ry 

3 days ago
Manufacturing

Ex­clu­sive: Com­mons Clin­ic rais­es $26M Se­ries B to of­fer pre­ven­tive test­ing

3 days ago
Financing
Startups

BioN­Tech to ac­quire Cure­Vac in all-stock deal val­ued at $1.25B

3 days ago
Deals

Schrödinger says ear­ly MALT1 da­ta could lay 'great foun­da­tion' for com­bos

3 days ago
R&D
1234 Next page Last page
A service from the Financial Times